相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic targets in myeloma bone disease
Silvia Marino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice
Silvia Marino et al.
EBIOMEDICINE (2019)
Multiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone microenvironment
Sam W. Z. Olechnowicz et al.
SCIENTIFIC REPORTS (2019)
The Proteasome and Myeloma-Associated Bone Disease
Fabrizio Accardi et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo
M. Victoria Barbado et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor
Silvia Marino et al.
PHARMACOLOGICAL RESEARCH (2017)
Multiple myeloma in the marrow: pathogenesis and treatments
Heather Fairfield et al.
MARROW (2016)
Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease
Jeffry S. Nyman et al.
BONE (2016)
Increased NF-κB Activity and Decreased Wnt/β-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice
Carole Le Henaff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity
John D. Douglass et al.
JOURNAL OF LIPID RESEARCH (2015)
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption
Rentian Feng et al.
MOLECULAR CARCINOGENESIS (2015)
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche
Michelle A. Lawson et al.
NATURE COMMUNICATIONS (2015)
The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation
Marie Smith et al.
PLOS ONE (2015)
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-
Maria Beatrice Morelli et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Therapeutic potential of monoacylglycerol lipase inhibitors
Melinda M. Mulvihill et al.
LIFE SCIENCES (2013)
NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation
Jia Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The endocannabinoid signaling system in cancer
Simona Pisanti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Monoacylglycerol lipase - a target for drug development?
C. J. Fowler
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models
Jinsong Hu et al.
DISEASE MODELS & MECHANISMS (2012)
Monoacylglycerol Lipase Exerts Dual Control over Endocannabinoid and Fatty Acid Pathways to Support Prostate Cancer
Daniel K. Nomura et al.
CHEMISTRY & BIOLOGY (2011)
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain
Iryna A. Khasabova et al.
PHARMACOLOGICAL RESEARCH (2011)
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Daniel K. Nomura et al.
SCIENCE (2011)
Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBF beta-dependent expression of the Wnt antagonist, sclerostin
Daniel Mendoza-Villanueva et al.
BREAST CANCER RESEARCH (2011)
Cannabinoids and Bone: Friend or Foe?
Aymen I. Idris et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Small molecule inhibitors of IκB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo
Aymen I. Idris et al.
FASEB JOURNAL (2010)
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss
Alysia N. Lozano-Ondoua et al.
LIFE SCIENCES (2010)
Cannabinoids and the skeleton: From marijuana to reversal of bone loss
Itai Bab et al.
ANNALS OF MEDICINE (2009)
The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption
F. Rossi et al.
BONE (2009)
Pharmacologic inhibitors of IκB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo
Aymen I. Idris et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling
Joseph Tam et al.
FASEB JOURNAL (2008)
Endocannabinoids and the regulation of bone metabolism
I. Bab et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate enerpv balance, metabolism, and cardiovascular health
Daniela Cota
DIABETES-METABOLISM RESEARCH AND REVIEWS (2007)
Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling
Joseph Tam et al.
MOLECULAR PHARMACOLOGY (2006)
分享论文
